The immunomodulatory agent lenalidomide (Revlimid) appeared clinically active and tolerable in pilocytic astrocytomas and optic pathway...

With a particular focus on glioma, Dr Peter J Houghton from Greehey Children’s Cancer Research Institute outlines the barriers that have...

Treatment with tovorafenib led to a 64% overall response rate in patients with recurrent or progressive pediatric low-grade glioma, study...

The combination of two targeted therapies, the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib, significantly increased the...

Scientists have found a novel cause of aggressive pediatric brain cancer. The St. Jude Children's Research Hospital study is the first to...

Researchers at University College London have discovered that disulfiram, an anti-alcoholism drug, may help to kill glioma cells in...

Geneticists from Trinity College Dublin have discovered how a specific genetic mutation called H3K27M causes a devastating, incurable ...

Researchers have discovered that removing copper from the blood can destroy some of the deadliest cancers that are resistant to...

Brain cancer in infants is biologically distinct from other childhood brain tumors and could be successfully treated with targeted drugs,...

Researchers have tested a new drug combination that shows promise for the treatment of several types of childhood brain cancers known as...